Arcus Biosciences, Inc. (RCUS)
21.97
-0.73
(-3.22%)
USD |
NYSE |
Mar 13, 16:00
21.95
-0.02
(-0.09%)
After-Hours: 20:00
Arcus Biosciences Market Cap : 2.754B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 179.99B |
| Eli Lilly & Co. | 879.67B |
| Merck & Co., Inc. | 285.83B |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
| Regeneron Pharmaceuticals, Inc. | 78.84B |
Market Cap Related Metrics
| PS Ratio | 9.560 |
| PEG Ratio | -1.025 |
| Price to Book Value | 4.364 |
| Price | 21.97 |
| Earnings Yield | -15.02% |
| PEGY Ratio | -1.025 |